Hyloris Pharmaceuticals 2023 Investor Presentation

Hyloris Pharmaceuticals is a Belgium-based pharmaceutical company focused on reformulating and repurposing existing chemical entities to address unmet medical needs. The company maintains a growing portfolio of 30+ cardio and value-added medicine assets with a €350 million market cap, trading on Euronext Brussels since its 2012 founding.